Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
8
|
| pubmed:dateCreated |
1993-11-16
|
| pubmed:abstractText |
The possibility of improving the performance of heart valve bioprostheses by preendothelialization with autologous cells has been suggested. In this study we used cultured adult human vein endothelial cells to endothelialize cusps isolated from commercially available porcine valve bioprostheses. We also describe a method for primary endothelialization of the intact heart valve bioprosthesis. After detoxification of the glutaraldehyde, the cusps or valves were seeded at high density with cultured cells. To obtain an even distribution on the intact valve bioprosthesis, a device was designed which permits application of cells from different directions during rotation. Evaluation was performed by hematoxylin-eosin staining, scanning electron microscopy and immunohistochemistry of the von Willebrand factor and the human basement membrane constituent collagen IV. The endothelial cells were vital-stained during culture by the addition to the culture medium of carbocyanine dye. This made it possible to verify that the endothelium was derived from culture. A confluent lining of cultured endothelial cells in close proximity to a de novo formed basement membrane was observed on the isolated cusps 7 days after seeding. The intact heart valve bioprosthesis showed an even distribution of seeded cells with areas of cells spreading to confluency as evaluated after 24 h. However, 7 days after seeding only unspread and probably dead cells were observed.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:status |
MEDLINE
|
| pubmed:issn |
1010-7940
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
7
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
393-8
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading | |
| pubmed:year |
1993
|
| pubmed:articleTitle |
In vitro endothelialization of commercially available heart valve bioprostheses with cultured adult human cells.
|
| pubmed:affiliation |
Department of Thoracic Surgery, Karolinska Hospital, Stockholm, Sweden.
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|